These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 19414341

  • 1. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
    Kashima H, Horiuchi A, Uchikawa J, Miyamoto T, Suzuki A, Ashida T, Konishi I, Shiozawa T.
    Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
    [Abstract] [Full Text] [Related]

  • 2. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression.
    Uchikawa J, Shiozawa T, Shih HC, Miyamoto T, Feng YZ, Kashima H, Oka K, Konishi I.
    Cancer; 2003 Nov 15; 98(10):2207-13. PubMed ID: 14601091
    [Abstract] [Full Text] [Related]

  • 3. Expression of nuclear receptors and cofactors in human endometrium and myometrium.
    Vienonen A, Miettinen S, Bläuer M, Martikainen PM, Tomás E, Heinonen PK, Ylikomi T.
    J Soc Gynecol Investig; 2004 Feb 15; 11(2):104-12. PubMed ID: 14980312
    [Abstract] [Full Text] [Related]

  • 4. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
    Villavicencio A, Bacallao K, Avellaira C, Gabler F, Fuentes A, Vega M.
    Gynecol Oncol; 2006 Oct 15; 103(1):307-14. PubMed ID: 16677694
    [Abstract] [Full Text] [Related]

  • 5. Expression of nuclear receptor coregulators in ovarian stromal and epithelial tumours.
    Hussein-Fikret S, Fuller PJ.
    Mol Cell Endocrinol; 2005 Jan 14; 229(1-2):149-60. PubMed ID: 15607539
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
    Zhao S, Chen X, Lu X, Yu Y, Feng Y.
    Gynecol Oncol; 2007 Apr 14; 105(1):45-54. PubMed ID: 17240435
    [Abstract] [Full Text] [Related]

  • 10. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.
    Myers E, Hill AD, Kelly G, McDermott EW, O'Higgins NJ, Buggy Y, Young LS.
    Clin Cancer Res; 2005 Mar 15; 11(6):2111-22. PubMed ID: 15788656
    [Abstract] [Full Text] [Related]

  • 11. Sexual dimorphism in the content of progesterone and estrogen receptors, and their cofactors in the lung of adult rats.
    González-Arenas A, Neri-Gómez T, Guerra-Araiza C, Camacho-Arroyo I.
    Steroids; 2004 May 15; 69(5):351-6. PubMed ID: 15219413
    [Abstract] [Full Text] [Related]

  • 12. Ski-interacting protein, a bifunctional nuclear receptor coregulator that interacts with N-CoR/SMRT and p300.
    Leong GM, Subramaniam N, Issa LL, Barry JB, Kino T, Driggers PH, Hayman MJ, Eisman JA, Gardiner EM.
    Biochem Biophys Res Commun; 2004 Mar 19; 315(4):1070-6. PubMed ID: 14985122
    [Abstract] [Full Text] [Related]

  • 13. Expression of estrogen receptor co-regulators SRC-1, RIP140 and NCoR and their interaction with estrogen receptor in rat uterus, under the influence of ormeloxifene.
    Daverey A, Saxena R, Tewari S, Goel SK, Dwivedi A.
    J Steroid Biochem Mol Biol; 2009 Aug 19; 116(1-2):93-101. PubMed ID: 19460436
    [Abstract] [Full Text] [Related]

  • 14. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK, McConnell T, Potoczek M, Emmons RV, Kurman RJ.
    Hum Pathol; 2010 Jan 19; 41(1):26-32. PubMed ID: 19733383
    [Abstract] [Full Text] [Related]

  • 15. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia.
    Vereide AB, Kaino T, Sager G, Arnes M, Ørbo A.
    Gynecol Oncol; 2006 May 19; 101(2):214-23. PubMed ID: 16325240
    [Abstract] [Full Text] [Related]

  • 16. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M, Shen K, Yang JX, Huang HF, Wu M, Pan LY, Lang JH, Lian LJ.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr 19; 41(4):242-5. PubMed ID: 16759458
    [Abstract] [Full Text] [Related]

  • 17. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
    Chien PY, Ito M, Park Y, Tagami T, Gehm BD, Jameson JL.
    Mol Endocrinol; 1999 Dec 19; 13(12):2122-36. PubMed ID: 10598586
    [Abstract] [Full Text] [Related]

  • 18. Regulation of the content of progesterone and estrogen receptors, and their cofactors SRC-1 and SMRT by the 26S proteasome in the rat brain during the estrous cycle.
    Villamar-Cruz O, Manjarrez-Marmolejo J, Alvarado R, Camacho-Arroyo I.
    Brain Res Bull; 2006 Apr 14; 69(3):276-81. PubMed ID: 16564422
    [Abstract] [Full Text] [Related]

  • 19. Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones.
    Havrilesky LJ, McMahon CP, Lobenhofer EK, Whitaker R, Marks JR, Berchuck A.
    J Soc Gynecol Investig; 2001 Apr 14; 8(2):104-13. PubMed ID: 11336882
    [Abstract] [Full Text] [Related]

  • 20. Bag-1M inhibits the transactivation of the glucocorticoid receptor via recruitment of corepressors.
    Hong W, Baniahmad A, Li J, Chang C, Gao W, Liu Y.
    FEBS Lett; 2009 Aug 06; 583(15):2451-6. PubMed ID: 19595997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.